Non-infectious Pulmonary Complications in Children with Primary Immunodeficiency

Primary immune deficiency (PID) is a large group of diseases characterized by defective immune function, leading to recurrent infections, and immune dysregulation. Clinical presentations, severity, and complications differ for each disease, based on the components of the immune system that are impacted. When patients with PID present with respiratory symptoms, infections should be initially suspected, investigated, and promptly managed. However, non-infectious complications of PID also frequently occur and can lead to significant morbidity and mortality. They can involve both the upper and lower respiratory systems, resulting in various presentations that mimic infectious diseases. Thus, clinicians should be able to detect these conditions and make an appropriate referral to an immunologist and a pulmonologist for further management. In this article, we use case-based scenarios to review the differential diagnosis, investigation, and multidisciplinary treatment of non-infectious pulmonary complications in patients with primary immune deficiencies.

[1]  B. Fevang,et al.  Diagnostic testing for interstitial lung disease in common variable immunodeficiency: a systematic review , 2023, Frontiers in Immunology.

[2]  R. Sherkat,et al.  Non-Infectious Complications in B-Lymphopenic Common Variable Immunodeficiency. , 2023, Journal of investigational allergology & clinical immunology.

[3]  S. Pakhalé,et al.  Mulch pneumonitis in a patient with chronic granulomatous disease , 2022, Canadian Medical Association Journal.

[4]  E. Secord,et al.  Humoral Immune Deficiencies of Childhood. , 2021, Immunology and allergy clinics of North America.

[5]  Y. Rosen Pathology of Granulomatous Pulmonary Diseases. , 2021, Archives of pathology & laboratory medicine.

[6]  C. Cunningham-Rundles,et al.  Interstitial Lung Disease in Common Variable Immunodeficiency , 2021, Frontiers in Immunology.

[7]  A. Pastorino,et al.  Inflammatory manifestations in children with chronic granulomatous disease , 2021, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[8]  S. Pacheco,et al.  Pulmonary Manifestations of Immunodeficiency and Immunosuppressive Diseases Other than Human Immunodeficiency Virus. , 2021, Pediatric clinics of North America.

[9]  Smita Y. Patel,et al.  Histology of Interstitial Lung Disease in Common Variable Immune Deficiency , 2020, Frontiers in Immunology.

[10]  Xi-hong Hu,et al.  Imaging findings of pulmonary manifestations of chronic granulomatous disease in a large single center from Shanghai, China (1999–2018) , 2020, Scientific Reports.

[11]  A. Gennery,et al.  LONG-TERM OUTCOMES FOR ADULTS WITH CHRONIC GRANULOMATOUS DISEASE IN THE UNITED KINGDOM. , 2020, The Journal of allergy and clinical immunology.

[12]  J. Verbsky,et al.  Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency. , 2020, The Journal of allergy and clinical immunology.

[13]  Yao-Hsu Yang,et al.  Chronic Granulomatous Disease: a Comprehensive Review , 2020, Clinical Reviews in Allergy & Immunology.

[14]  M. Lawrence,et al.  Birds of a feather: common variable immune deficiencies. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[15]  V. Lougaris,et al.  Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies. , 2019, The Journal of allergy and clinical immunology.

[16]  F. Cinetto,et al.  Appropriate lung management in patients with primary antibody deficiencies , 2019, Expert review of respiratory medicine.

[17]  C. Cunningham-Rundles,et al.  Autoimmunity in Common Variable Immunodeficiency. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[18]  D. Wesemann,et al.  Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease. , 2019, Chest.

[19]  Ivan K. Chinn,et al.  Treatment-Responsive Granulomatous-Lymphocytic Interstitial Lung Disease in a Pediatric Case of Common Variable Immunodeficiency , 2019, Front. Pediatr..

[20]  K. Kelley,et al.  British Society for Immunology/United Kingdom Primary Immunodeficiency Network consensus statement on managing non‐infectious complications of common variable immunodeficiency disorders , 2019, Clinical and experimental immunology.

[21]  D. Lynch,et al.  Pulmonary Manifestations of Common Variable Immunodeficiency. , 2018, Journal of thoracic imaging.

[22]  F. Cinetto,et al.  The broad spectrum of lung diseases in primary antibody deficiencies , 2018, European Respiratory Review.

[23]  P. Soler-Palacín,et al.  The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation , 2018, Front. Immunol..

[24]  S. Henrickson,et al.  Noninfectious Manifestations and Complications of Chronic Granulomatous Disease , 2018, Journal of the Pediatric Infectious Diseases Society.

[25]  M. Juan,et al.  Sirolimus as an alternative treatment in patients with granulomatous‐lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T cells , 2018, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[26]  Smita Y. Patel,et al.  British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders. , 2017, The journal of allergy and clinical immunology. In practice.

[27]  Ivan K. Chinn,et al.  Update on the use of immunoglobulin in human disease: A review of evidence , 2017, The Journal of allergy and clinical immunology.

[28]  R. Gavrieli,et al.  Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients , 2017, American journal of hematology.

[29]  M. Beasley,et al.  Lung Disease in Primary Antibody Deficiencies. , 2016, The journal of allergy and clinical immunology. In practice.

[30]  Jonathan H. Chung,et al.  Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease. , 2016, Annals of the American Thoracic Society.

[31]  M. Zumberg,et al.  Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency , 2016, BMJ Case Reports.

[32]  K. Flaherty,et al.  Idiopathic non‐specific interstitial pneumonia , 2016, Respirology.

[33]  A. Mackinnon,et al.  Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency--histologic and immunohistochemical analyses of 16 cases. , 2015, Human pathology.

[34]  Grey Held Cryptogenic organizing pneumonia , 2015, Definitions.

[35]  J. Aróstegui,et al.  Non-Hodgkin lymphoma in pediatric patients with common variable immunodeficiency , 2015, European Journal of Pediatrics.

[36]  A. Fischer,et al.  Pulmonary manifestations in adult patients with chronic granulomatous disease , 2015, European Respiratory Journal.

[37]  P. Bánovčin,et al.  Pulmonary Manifestations of Primary Immunodeficiency Disorders in Children , 2014, Front. Pediatr..

[38]  E. Stovold,et al.  Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review , 2014, European Respiratory Journal.

[39]  J. Verbsky,et al.  Sarcoidosis and Common Variable Immunodeficiency: Similarities and Differences , 2014, Seminars in Respiratory and Critical Care Medicine.

[40]  G. Kayser,et al.  Common variable immunodeficiency-associated granulomatous and interstitial lung disease , 2013, Current opinion in pulmonary medicine.

[41]  J. Casanova,et al.  Pulmonary manifestations of chronic granulomatous disease , 2013, Expert review of clinical immunology.

[42]  Smita Y. Patel,et al.  Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. , 2012, The Journal of allergy and clinical immunology.

[43]  P. Brillet,et al.  Granulomatosis-associated common variable immunodeficiency disorder: a case–control study versus sarcoidosis , 2012, European Respiratory Journal.

[44]  V. Chernick,et al.  Kendig and Chernick's disorders of the respiratory tract in children , 2012 .

[45]  C. Cunningham-Rundles,et al.  Morbidity and mortality in common variable immune deficiency over 4 decades. , 2012, Blood.

[46]  A. Fischer,et al.  Hodgkin lymphoma in 2 children with chronic granulomatous disease. , 2011, The Journal of allergy and clinical immunology.

[47]  J. Orange,et al.  Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  S. Roberts,et al.  Fulminant Mulch Pneumonitis in Undiagnosed Chronic Granulomatous Disease: A Medical Emergency , 2010, Clinical pediatrics.

[49]  B. Fevang,et al.  Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[50]  A. Towbin,et al.  Chronic granulomatous disease , 2010, Pediatric Radiology.

[51]  A. Levinson,et al.  Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). , 2010, Clinical immunology.

[52]  Dirk Roos,et al.  Chronic Granulomatous Disease: The European Experience , 2009, PloS one.

[53]  Lennart Hammarstrom,et al.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes. , 2008, Blood.

[54]  R. Seger Modern management of chronic granulomatous disease , 2008, British journal of haematology.

[55]  S. Holland,et al.  Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  James B Fink,et al.  Forced expiratory technique, directed cough, and autogenic drainage. , 2007, Respiratory care.

[57]  N. Bogot,et al.  Lymphocytic interstitial pneumonia associated with common variable immunodeficiency resolved with intravenous immunoglobulins , 2006, Thorax.

[58]  D. Lynch,et al.  Lung Diseases in Patients With Common Variable Immunodeficiency: Chest Radiographic, and Computed Tomographic Findings , 2006, Journal of computer assisted tomography.

[59]  J. Orange,et al.  Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. , 2006, The Journal of allergy and clinical immunology.

[60]  N. Rezaei,et al.  Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency , 2006, Leukemia & lymphoma.

[61]  V. Cottin,et al.  Cryptogenic Organizing Pneumonia , 2005, Seminars in Respiratory and Critical Care Medicine.

[62]  A. Chang,et al.  Hospital-Based Case-Control Study of Bronchiectasis in Indigenous Children in Central Australia , 2004, The Pediatric infectious disease journal.

[63]  D. Lynch,et al.  Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. , 2004, The Journal of allergy and clinical immunology.

[64]  H. Carty,et al.  Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. , 2003, European journal of radiology.

[65]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[66]  F. Reichenberger,et al.  Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient with Common Variable Immunodeficiency Syndrome , 2001, Respiration.

[67]  A. Anstey,et al.  The dermatosis of chronic granulomatous disease , 2000, Clinical and experimental dermatology.

[68]  Richard B. Johnston,et al.  Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.

[69]  H. Fabel,et al.  Sarcoidosis and Common Variable Immunodeficiency , 2000, Respiration.

[70]  W. Redekop,et al.  Increased risk of malignancy for patients with chronic granulomatous disease and its possible link to the pathogenesis of cancer. , 1996, European journal of cancer.

[71]  R. Gupta,et al.  Pulmonary ventilation and gas exchange in bronchiectasis , 1971, Thorax.

[72]  C. Cunningham-Rundles,et al.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. , 2016, The journal of allergy and clinical immunology. In practice.

[73]  É. Oksenhendler,et al.  Granulomatous Disease in CVID: Retrospective Analysis of Clinical Characteristics and Treatment Efficacy in a Cohort of 59 Patients , 2012, Journal of Clinical Immunology.

[74]  L. Goodman,et al.  Use of Combination Chemotherapy for Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD) in Patients with Common Variable Immunodeficiency (CVID) , 2012, Journal of Clinical Immunology.

[75]  F. Mccool,et al.  Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines. , 2006, Chest.

[76]  S. Swensen,et al.  Bronchiolar disorders. , 2003, American journal of respiratory and critical care medicine.

[77]  M. Koss,et al.  LYMPHOID INTERSTITIAL PNEUMONIA: CLINICOPATHOLOGICAL AND IMMUNOPATHOLOGICAL FINDINGS IN 18 CASES , 1987, Pathology.

[78]  R. Stockley Bronchiectasis--new therapeutic approaches based on pathogenesis. , 1987, Clinics in chest medicine.